TRANSCHEM LTD.
Latest filings
- Transchem 49th AGM voting results: All 3 resolutions passed · Board & Shareholder Meetings
- Transchem 49th AGM: pivot to financial services, Greshma acquisition completed · Board & Shareholder Meetings
- Transchem acquires 100% of Greshma Shares and Stocks for about INR 25.91 crore · Strategic Transactions
- Transchem acquires 100% of Greshma Shares and Stocks for Rs 25.91 cr · Strategic Transactions
- Newspaper advertisement of Q1 FY27 unaudited financial results · Compliance
- Monitoring Agency Report on Transchem Preferential Warrant Issue Q1 FY27 · Fund Raising
- Transchem board approves amended Insider Trading Code · Compliance
- Transchem Q1 FY27 net profit surges to Rs 342 lakh · Results
- Board approves Q1 FY27 results, net profit up 3.4x at Rs 342 lakh · Board & Shareholder Meetings
- Board meeting on Aug 10 to consider Q1 FY27 unaudited results · Results
- Newspaper ad for 49th AGM notice and remote e-voting info · Compliance
- Transchem 49th AGM notice and FY26 annual report dispatch · Board & Shareholder Meetings
- 49th AGM on Sept 5, 2026; book closure Aug 30 to Sept 5; FY26 annual report filed · Board & Shareholder Meetings
- Transchem 49th AGM on Sep 5, 2026; book closure Aug 30 to Sep 5 · Board & Shareholder Meetings
- Routine RTA compliance certificate under SEBI Reg 74(5) for Q1 FY27 · Compliance
- Trading Window Closure Ahead of Q1 FY26 Results · Compliance
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bakkt Opco Holdings, LLC · Ownership Changes
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pishu V Chainani · Ownership Changes
- Please refer the attached intimation. · Fund Raising
- Please refer the attached intimation. · Fund Raising
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Fund Raising
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Fund Raising
- <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> .... · Compliance
- Please refer the attached intimation · Compliance
- Re-appointment of M/s. L. T. Jadav & Co., Chartered Accountants as the Internal Auditors of the Company for the F.Y. 2026-2027 · General
- Please refer the attached intimation · Results
- Please refer the attached intimation · Results
- Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 ,inter alia, to consider and approve the Audited Financial Results of .... · Results
- <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> .... · Compliance
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Results
- Please refer the attached intimation. · Results
- Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Un-Audited Financial Results of .... · Results
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Corporate Actions
- Please refer the attached intimation. · Board & Shareholder Meetings
- Please refer the attached intimation. · Board & Shareholder Meetings
- Please refer the attached intimation. · Compliance
- Please refer the attached Intimation. · Board & Shareholder Meetings
- Please refer the attached intimation. · Compliance
- Please refer the attached intimation. · Board & Shareholder Meetings
- Please refer the attached Intimation. · Board & Shareholder Meetings
- Please refer the attached Intimation. · Board & Shareholder Meetings
- Please refer the attached Intimation. · Board & Shareholder Meetings
- Please refer the attached intimation. · Fund Raising
Snapshot
What the business is, and whether it's a good one at a fair price.
Classified under pharmaceuticals, the company reported total income of Rs 926.08 lakhs in FY26, but operating revenue in Q3 FY26 was just Rs 20.60 lakhs — the bulk of income came from 'other income' sources. It holds cash reserves of Rs 4,242.91 lakh and posted net profit of Rs 429.51 lakhs, though operating cash flow turned negative at minus Rs 156.59 lakh for the year. The company has allotted 6.15 crore warrants at Rs 75 each, of which Rs 110 crore of proceeds is earmarked for strategic acquisitions in the broking and allied financial services sector, with target entities intended to become subsidiaries. Another Rs 115 crore is allocated for general corporate purposes to be utilised within 6-18 months. The largest allottee is Bakkt Opco Holdings, LLC (a US entity owned by NYSE-listed Bakkt Inc.), which received 4.75 crore warrants representing 64.42% of fully diluted share capital upon conversion.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from TRANSCHEM LTD.'s filed financials and exchange disclosures
What does TRANSCHEM LTD. do?
TRANSCHEM LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.
Is TRANSCHEM LTD. profitable?
Yes. Over the trailing twelve months TRANSCHEM LTD. reported a net profit of ₹4 Cr on revenue of ₹0 Cr.
Does TRANSCHEM LTD. pay a dividend?
Not in the latest reported year — TRANSCHEM LTD.'s dividend payout for FY26 was nil.
Is TRANSCHEM LTD. debt-free?
Effectively yes. It holds ₹42 Cr more cash than debt. Debt stands at 0.00× equity.
Is TRANSCHEM LTD. expensive compared with its peers?
On trailing P/E, TRANSCHEM LTD. ranks 163 of 170 in Pharmaceuticals — cheaper than 4% of them, against an industry median of 29.6×. This is a position, not a valuation judgement.
How much does the TRANSCHEM LTD. share price move in a day?
On a typical session TRANSCHEM LTD. moves 2.00% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Where can I track TRANSCHEM LTD.'s announcements?
Every NSE and BSE filing by TRANSCHEM LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.